The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
The bill that President Donald Trump signed Monday night to reopen the federal government included a two-year delay in implementing a tax on medical devices, bringing praise from Indiana-based Cook Group.
Scientists are reporting progress on a blood test to detect many types of cancer at an early stage, including some of the most deadly ones that lack screening tools.
Several major not-for-profit hospital groups, including the parent of St. Vincent Health in Indianapolis, are trying their own solution to drug shortages and high prices.
The future for cannabidiol, or CBD, oil in Indiana remains unclear after an Indiana senator declined to call for a vote on two bills that would legalize the sale of the substance if certain specifications are met.
About 80 percent of Indiana employers have been affected by prescription drug misuse and abuse, including opioid painkillers, in their workplaces, according to a survey by the National Safety Council.
A slimmed-down Eli Lilly and Co., thousands of employees lighter after its biggest restructuring in nearly a decade, is now looking high and low for deals to bulk up its drug pipeline.
The Trump administration said Thursday it will allow states to require "able-bodied" Medicaid recipients to work, a hotly debated first in the enormous program's half-century history.
Alex Azar, a former Eli Lilly and Co. executive, acknowledged to the Senate Finance Committee that drug prices are too high and said he'd work to lower them if confirmed as secretary of Health and Human Services.
One of the Indianapolis-area’s largest private companies is taking on a different name to better reflect its mission in livestock health.
Senate Bill 28 would offer grants of $5,000 a year to eligible instructors at Indiana nursing programs, with a lifetime cap of $25,000.
Former Eli Lilly exec Alex Azar, who is President Donald Trump’s pick to lead the Department of Health and Human Services, faces senators at his second hearing on Capitol Hill on Tuesday.
A wide array of cities, towns and counties are blaming opioid makers and distributors for flooding their communities with addictive painkillers.
Pfizer said it will continue its support of potential blockbuster drug tanezumab, a late-stage pain treatment in development with Indianapolis-based Eli Lilly and Co.
The medical-device industry will see a resumption of the 2.3 percent federal excise tax beginning this month, following a two-year moratorium that expired Dec. 31.
CleanSlate Centers, a fast-growing, venture-backed operation based in Nashville, Tennessee, said it has opened two outpatient treatment centers in Indianapolis and one in Bloomington.
HealthCare.gov enrollment reached nearly 95 percent of last year's level, outperforming projections in a show of consumer demand, despite a shortened sign-up season and big cuts in the ad budget.
U.S. Sen. Claire McCaskill is asking the Indianapolis-based insurer to turn over a huge array of internal documents, explaining how it reached its decision to deny certain emergency room claims.
Its impact will spread far and wide starting next year, highlighted by a cut in the corporate rate to 21 percent, fully allowable deductions for capital expenses and lower levies on repatriating overseas profits.
Riley Hospital for Children is about to begin renovating four floors of its hospital into a new, centralized maternity and newborn health unit.
